Gene therapy for treating propionic acidemia
US-2026041788-A1 · Feb 12, 2026 · US
Daugherty Sean Christopher is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Daugherty Sean Christopher |
| Total patents | 13 |
| First publication | Apr 9, 2020 |
| Latest publication | Feb 12, 2026 |
Publications ranked by popularity score, then publication date.
US-2026041788-A1 · Feb 12, 2026 · US
US-12472268-B2 · Nov 18, 2025 · US
US-2025297251-A1 · Sep 25, 2025 · US
US-11939600-B2 · Mar 26, 2024 · US
US-2023348906-A1 · Nov 2, 2023 · US
US-2023129893-A1 · Apr 27, 2023 · US
US-2023054144-A1 · Feb 23, 2023 · US
US-2022340886-A1 · Oct 27, 2022 · US
US-2022220189-A1 · Jul 14, 2022 · US
US-11377643-B2 · Jul 5, 2022 · US
Latest publications not already listed above.
US-2021283272-A1 · Sep 16, 2021 · US
US-2020149017-A1 · May 14, 2020 · US
US-2020109375-A1 · Apr 9, 2020 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ultragenyx Pharmaceutical Inc | 11 |
| Univ Saint Louis | 2 |
| Arcturus Therapeutics Inc | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K48/005 | 10 |
| C12N2800/22 | 8 |
| A61K48/00 | 6 |
| A61K31/7115 | 5 |
| C12N2830/50 | 5 |